Here is what I would love to see with NOVN being I'm a big NOVN bull bag holder. ;)
Looks like bond yields have gone risk on but the stock market hasn't caught onto this quiet yet. Heavy resistance incoming, break .79 and the bulls will party
$NOVN has a couple different roads to choose from both leading to the same destination IMO
$NOVN RSI way overbought, could reject here retest .36c B4 breaking up or could just power through straight to .80c So I am holding & watching
Thinking something like this.. Follow the links in my bio for the full video.
On fire fam hope you bought in.. I been posting videos everyday about this 1
$NOVN entered gap area yesterday, did not have enough follow thru. I am thinking a dip towards 1.15 (premarket low) or towards 1.06 to 1.09 (200 DMA) would be the best entry, risking 0.98 stop loss. Price Target is just below gap fill at 1.83, for a 1:4 RR. @architrader
I think this is probably where I will place bids on NOVN.. Still looking weak AF right now.
I think it will move fast and aggressive within the next few days .. to be in the safe zone the stop loss is closing under 0.5$
Looks like we were able to close a green candle on the other side of the bollinger band median this week crossing on weekly chart. To me its a clear indication of indicates long term bullish trend. Win loss ratio looks good as well. What do you guys think about it? Does it really make sense? I didn quite at the right time with so decided not to sell for now. Any...
Above Moving Averages Gap Fill @ $0.54 Finally Looks Like Breakout Happening Nitric Oxide Research Going Well
Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in...
$NOVN is in a bull flag and on the verge of a breakout. The way to trade is to go long $NOVN above $3. A move above $3 will test the 52-week highs of $3.24. A move above $3.24 and we will look to close the gap to $4.19. Risk is minimal as a move above $3 should work out right away. If $NOVN closes the gap, upside is 40%. Not a bad risk/reward play is it? As...
Pharmaceutical stocks represents a defensive asset when a positive market cycle is about to finish or when it is foreseen a cycle less positive than the previous one. In such context pharma stocks should have an advantage because of inelastic demand for such goods. Novartis ($NVS,$NOVN) is one of the candidate to break up as the price is moving in a triangle...